| Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type |
| A1 | 1 | 69 | F | Esophagus | Squamous cell carcinoma | 2 | T3N0M0 | IIB | Malignant |
| A2 | 2 | 69 | F | Esophagus | Adjacent normal esophagus tissue | * | * | * | NAT |
| A3 | 3 | 61 | F | Liver | Hepatocellular carcinoma | 2 | T3N1M0 | IVA | Malignant |
| A4 | 4 | 61 | F | Liver | Cancer adjacent liver tissue | * | * | * | AT |
| A5 | 5 | 29 | F | Breast | Invasive carcinoma of no special type | 3 | T2N0M0 | IIA | Malignant |
| A6 | 6 | 29 | F | Breast | Cancer adjacent breast tissue | * | * | * | AT |
| A7 | 7 | 64 | M | Prostate | Adenocarcinoma (Gleason grade:5, Gleason score:5+5) | 3 | T2N0M0 | II | Malignant |
| A8 | 8 | 64 | M | Prostate | Cancer adjacent prostate tissue | * | * | * | AT |
| B1 | 9 | 72 | M | Esophagus | Squamous cell carcinoma | 3 | T3N0M0 | IIB | Malignant |
| B2 | 10 | 72 | M | Esophagus | Adjacent normal esophagus tissue | * | * | * | NAT |
| B3 | 11 | 45 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | IIIA | Malignant |
| B4 | 12 | 45 | M | Liver | Adjacent normal liver tissue | * | * | * | NAT |
| B5 | 13 | 49 | F | Breast | Invasive carcinoma of no special type | 2 | T2N2aM0 | IIIA | Malignant |
| B6 | 14 | 49 | F | Breast | Cancer adjacent breast tissue | * | * | * | AT |
| B7 | 15 | 71 | M | Prostate | Adenocarcinoma (Gleason grade:2, Gleason score:3+4) | 2 | T2N0M0 | II | Malignant |
| B8 | 16 | 71 | M | Prostate | Cancer adjacent prostate tissue | * | * | * | AT |
| C1 | 17 | 67 | M | Stomach | Adenocarcinoma | 2 | T2N1M0 | IIA | Malignant |
| C2 | 18 | 67 | M | Stomach | Adjacent normal stomach tissue | * | * | * | NAT |
| C3 | 19 | 45 | M | Kidney | Clear cell carcinoma | 1 | T1N0M0 | I | Malignant |
| C4 | 20 | 45 | M | Kidney | Adjacent normal kidney tissue | * | * | * | NAT |
| C5 | 21 | 42 | F | Ovary | Serous adenocarcinoma | 3 | T1N0M0 | I | Malignant |
| C6 | 22 | 38 | F | Ovary | Adjacent normal ovary tissue | * | * | * | NAT |
| C7 | 23 | 49 | F | Brain | Anaplastic astrocytoma | 3 | * | * | Malignant |
| C8 | 24 | 49 | F | Brain | Adjacent normal brain tissue | * | * | * | NAT |
| D1 | 25 | 68 | M | Stomach | Adenocarcinoma | 2 | T3N0M0 | IIB | Malignant |
| D2 | 26 | 68 | M | Stomach | Adjacent normal stomach tissue | * | * | * | NAT |
| D3 | 27 | 54 | M | Kidney | Clear cell carcinoma | 1 | T1N0M0 | I | Malignant |
| D4 | 28 | 54 | M | Kidney | Adjacent normal kidney tissue | * | * | * | NAT |
| D5 | 29 | 42 | F | Ovary | Serous adenocarcinoma | 3 | T1bN0M0 | IB | Malignant |
| D6 | 30 | 45 | F | Ovary | Adjacent normal ovary tissue | * | * | * | NAT |
| D7 | 31 | 22 | F | Brain | Glioblastoma | 4 | * | * | Malignant |
| D8 | 32 | 22 | F | Brain | Cancer adjacent brain tissue | * | * | * | AT |
| E1 | 33 | 57 | M | Colon | Adenocarcinoma with necrosis | 2 | T3N1M0 | IIIB | Malignant |
| E2 | 34 | 57 | M | Colon | Adjacent normal colon tissue | * | * | * | NAT |
| E3 | 35 | 65 | F | Lung | Adenocarcinoma | 2 | T2N0M0 | IB | Malignant |
| E4 | 36 | 65 | F | Lung | Adjacent normal lung tissue | * | * | * | NAT |
| E5 | 37 | 29 | F | Cervix | Squamous cell carcinoma | 1 | T1bN0M0 | IB | Malignant |
| E6 | 38 | 29 | F | Cervix | Cancer adjacent cervix tissue | * | * | * | AT |
| E7 | 39 | 62 | M | Skin | Squamous cell carcinoma | 1 | T1N0M0 | I | Malignant |
| E8 | 40 | 62 | M | Skin | Cancer adjacent skin tissue | * | * | * | AT |
| F1 | 41 | 54 | M | Colon | Adenocarcinoma with necrosis | 2 | T3N1M0 | IIIB | Malignant |
| F2 | 42 | 54 | M | Colon | Adjacent normal colon tissue | * | * | * | NAT |
| F3 | 43 | 59 | M | Lung | Adenocarcinoma | * | T2N0M0 | IB | Malignant |
| F4 | 44 | 59 | M | Lung | Cancer adjacent lung tissue | * | * | * | AT |
| F5 | 45 | 45 | F | Cervix | Squamous cell carcinoma | 3 | T1N1M0 | IIIB | Malignant |
| F6 | 46 | 45 | F | Cervix | Cancer adjacent cervix tissue | * | * | * | AT |
| F7 | 47 | 15 | M | Skin | Squamous cell carcinoma | 3 | T2N0M0 | II | Malignant |
| F8 | 48 | 15 | M | Skin | Adjacent normal skin tissue | * | * | * | NAT |
| Tissue Marker |
